Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143,223,667
-
Total 13F shares
-
12,195,771
-
Share change
-
+399,367
-
Total reported value
-
$253,182,315
-
Price per share
-
$20.76
-
Number of holders
-
66
-
Value change
-
-$6,258,655
-
Number of buys
-
30
-
Number of sells
-
37
Institutional Holders of Applied Therapeutics, Inc. - Common Stock (APLT) as of Q3 2020
As of 30 Sep 2020,
Applied Therapeutics, Inc. - Common Stock (APLT) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,195,771 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, Knoll Capital Management, LP, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, EMERALD ADVISERS, LLC, and EMERALD MUTUAL FUND ADVISERS TRUST.
This page lists
66
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.